chronic stable angina (Qi stagnation and blood stasis syndrome)
Conditions
Interventions
Case Group:Quick-acting Jiuxin Pill
Control Group:Simulator of Quick-acting Jiuxin Pill
open group:Quick-acting Jiuxin Pill
Sponsors
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Those who meet the diagnostic criteria of coronary heart disease; 2. It conforms to the diagnostic criteria of stable exertional angina pectoris (CSS angina severity grade I-III); 3. Patients with angina pectoris twice or more per week; 4. Those who accord with traditional Chinese medical syndrome discrimination of qi stagnation and blood stasis; 5. The aged 18 to 80 years. 6. Sign informed consent.
Exclusion criteria
Exclusion criteria: 1) Myocardial infarction and moderate to severe heart failure occurred within 3 months; 2) Percutaneous coronary intervention or coronary artery bypass grafting or pacemaker implantation within 3 months; 3) Complicated with uncontrolled grade III hypertension (systolic blood pressure (> 180 mmHg) and/or diastolic blood pressure (> 110 mmHg), severe arrhythmia; 4) Chest pain caused by diseases other than coronary artery disease, such as psychosis, severe neurosis, hyperthyroidism, biliary heart syndrome, gastroesophageal reflux, aortic dissection, etc.; 5) The patients with liver, kidney, hematopoietic system and other serious diseases, including those with normal upper limit of ALT and AST > twice, and those with normal upper limit of serum creatinine (Scr) > 1.5 times 6) Anaphylaxis or allergic to the test drug ingredients; 7) Those who participated in other drug clinical trials within one month; 8) Researchers consider it inappropriate to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effect of angina pectoris ;;Incidence of cardiovascular events .; | — |
Secondary
| Measure | Time frame |
|---|---|
| Angina classification ;;Improvement of TCM syndromes ;;Seattle Angina Scale score;;The dosage of emergency drugs and the stopping rate ;;EKG efficacy.; | — |
Countries
China
Contacts
Public ContactXiaolong Wang
Outcome results
None listed